Papers - HATAKEYAMA SHINGO
-
Associations of remaining teeth number, periodontal disease, and occlusal support status with erectile dysfunction in community-dwelling men
Fujita N, Iwane T, Tamura Y, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Kobayashi W, Ohyama C.
Int J Urol. 31 2024.8
-
ASO Visual Abstract: Long-Term Outcomes of Orthotopic Neobladder versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium.
Chris Ho-Ming Wong, Ivan Ching-Ho Ko, Seok Ho Kang, Kousuke Kitamura, Shigeo Horie, Satoru Muto, Chikara Ohyama, Shingo Hatakeyama, Manish Patel, Cheung-Kuang Yang, Kittinut Kijvikai, Ji Youl Lee, Hai-Ge Chen, Rui-Yun Zhang, Tian-Xin Lin, Lui Shiong Lee, Jeremy Yuen-Chun Teoh, Eddie Chan
Annals of surgical oncology 31 ( 8 ) 5119 - 5120 2024.8
-
α2,3シアル化PSAとα1,6フコシル化PSAを組み合わせたSF indexによる前立腺癌診断
波多野 浩士, 米山 徹, 畠山 真吾, 冨山 栄輔, 土屋 睦美, 西本 光寿, 吉村 一宏, 三善 英知, 植村 天受, 大山 力, 野々村 祝夫, 藤田 和利
泌尿器外科 37 ( 8 ) 919 - 920 2024.8
-
TOPICS 泌尿器科学 前立腺癌の新規体外診断薬S2,3PSA%
大山 力, 米山 徹, 畠山 真吾
医学のあゆみ 290 ( 2 ) 182 - 183 2024.7
-
トピックス 新規前立腺癌診断マーカー S2,3PSA%の有用性
畠山 真吾, 米山 徹, 大山 力
検査と技術 52 ( 6 ) 568 - 570 2024.6
-
Association between sex hormones and erectile dysfunction in men without hypoandrogenism
Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C, Hatakeyama S.
Sci Rep 14 13433 2024.6
-
Impact of severe acute kidney injury on short-term mortality in urosepsis
42 2024.5
-
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Kikuchi Y, Shimada H, Yamasaki F, Yamashita T, Araki K, Horimoto K, Yajima S, Yashiro M, Yokoi K, Cho H, Ehira T, Nakahara K, Yasuda H, Isobe K, Hayashida T, Hatakeyama S, Akakura K, Aoki D, Nomura H, Tada Y, Yoshimatsu Y, Miyachi H, Takebayashi C, Hanamura I, Takahashi H.
Int J Clin Oncol. 2024.3
-
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
2024.3
-
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.
Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, Ichikawa T, Kamai T, Kaji Y, Kume H, Kondo T, Matsuyama H, Masumori N, Kawauchi A, Takenaka A, Uemura H, Eto M, Nonomura N, Fujii Y, Hinotsu S, Ohyama C.
2024.3
-
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study
Fujita N, Hatakeyama S, Tabata R, Okita K, Kido K, Hamano I, Tanaka T, Noro D, Tokui N, Suzuki Y, Yoneyama T, Hashimoto Y, Sato S, Ohyama C.
12 ( 1 ) 46 2024.3
-
Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study
Kodama H, Hatakeyama S, Matsuura T, Saito M, Nishida H, Hamaya T, Maita S, Murakami R, Tomita H, Saitoh H, Tsuchiya N, Habuchi T, Obara W, Ohyama C.
2024.2
-
Share Prognostic impact of histological discordance between transurethral resection and radical cystectomy
Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group.
2024.2
-
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H; Japanese Urological Oncology Group.
2024.1
-
Association between oral frailty and lower urinary tract symptoms among middle-aged and older adults in community-dwelling individuals: a cross-sectional study.
Yoneyama F, Okamoto T, Tamura Y, Ishii N, Togashi K, Soma O, Fujita N, Yamamoto H, Hatakeyama S, Kobayashi W, Ohyama C.
2024.1
-
多施設共同研究によるマージナルドナーから腎移植後グラフト予後の検討
小玉 寛健, 畠山 真吾, 松浦 朋彦, 齋藤 満, 西田 隼人, 米田 真也, 村上 礼一, 富田 泰史, 齋藤 久夫, 土谷 順彦, 羽渕 友則, 小原 航, 大山 力
移植 59 ( Supplement ) s283_3 - s283_3 2024
-
Impact of timing of rejection episode on cardiovascular events in living donor kidney transplantation: a multicenter retrospective study.
Okamoto T, Hatakeyama S, Hamaya T, Matsuura T, Saito M, Nishida H, Maita S, Murakami R, Tomita H, Saitoh H, Tsuchiya N, Habuchi T, Obara W, Ohyama C.
2023.12
-
Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study.
Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T.
2023.11
-
Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.
Tanaka R, Hatakeyama S, Narita S, Sakurai T, Tanaka T, Miura H, Oishi T, Kawamura S, Hoshi S, Ishidoya S, Mitsuzuka K, Ito A, Tsuchiya N, Habuchi T, Ohyama C.
2023.11
-
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
Kobayashi M, Numakura K, Hatakeyama S, Ishida T, Koizumi A, Tadachi K, Igarashi R, Takayama K, Muto Y, Sekine Y, Sobu R, Sasagawa H, Akashi H, Kashima S, Yamamoto R, Nara T, Saito M, Narita S, Ohyama C, Habuchi T.
2023.11